ADR,SEQ,ROUTE,MULTICONST,NONSERIOUS_SERIOUS_FATAL_NSF
1,1,ORAL USE,N,S
2,1,RECTAL USE,N,N
3,1,ORAL USE,N,N
4,1,ORAL USE,N,N
5,1,RECTAL USE,N,N
6,1,ORAL USE,N,N
7,1,ORAL USE,N,S
8,1,ORAL USE,N,S
9,1,ORAL USE,N,S
10,1,ORAL USE,N,S
11,1,RECTAL USE,N,N
12,1,ORAL USE,N,S
13,1,ORAL USE,N,N
14,1,RECTAL USE,N,S
15,1,ORAL USE,N,S
16,1,ORAL USE,N,S
17,1,ORAL USE,N,S
18,1,ORAL USE,N,N
19,1,ORAL USE,N,N
20,1,ORAL USE,N,S
21,1,ORAL USE,N,N
22,1,ORAL USE,N,N
23,1,ORAL USE,N,N
24,1,ORAL USE,N,S
25,1,RECTAL USE,N,N
26,1,Routes with few reports,N,S
27,1,ORAL USE,N,S
28,1,ORAL USE,N,S
29,1,VAGINAL USE,N,S
30,1,ORAL USE,N,N
31,1,ORAL USE,N,N
32,1,ORAL USE,N,S
33,1,ORAL USE,N,S
34,1,ORAL USE,N,S
35,1,ORAL USE,N,N
36,1,VAGINAL USE,N,N
37,1,ORAL USE,N,S
38,1,VAGINAL USE,N,N
39,1,ORAL USE,N,N
40,1,ORAL USE,N,S
41,1,VAGINAL USE,N,S
42,1,VAGINAL USE,N,N
43,1,ORAL USE,N,S
44,1,VAGINAL USE,N,N
45,1,ORAL USE,N,S
46,1,Routes with few reports,N,S
47,1,Routes with few reports,N,S
